NSN 6505-01-275-6048 · NIIN 012756048 · FSC 6505
NO DASHES 6505012756048
In Stock
THEOPHYLLINE EXTENDED-RELEASE CA
Drugs and Biologicals
Technical characteristics
7 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT 300.000 |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 500S BT |
| CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 500.000 |
| FEAT | SPECIAL FEATURES | ANHYDROUS |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| THPE | THERAPEUTIC EQUIVALENT | TO THEO-24 CR CAPSULES BY SEARLE LABORATORIES |
Cross-references
2 manufacturer part numbers on file for this NSN — each shown against the CAGE code it belongs to.
| Manufacturer part number | CAGE |
|---|---|
| NDC50111-0459-02 | 1BL76 |
| NDC50474-0300-50 | 66911 |